healthcare News
Cullinan Therapeutics falls 3.3% on widened losses despite earnings beat
Biotech ends 2025 with $439M cash position and multiple 2026 catalysts including CLN-978 data and zipalertinib NDA
Esperion swings to profit as acquisition expands cardiovascular franchise
Drugmaker posts $61.8M Q4 profit, seals $75M Corstasis deal for Enbumyst nasal diuretic
Rapport Therapeutics accelerates Phase 3 epilepsy trials after data success
Cash position of $490.5M supports pipeline expansion into H2 2029 as Tenacia deal adds $308M milestone potential
Apyx Medical surges after reporting first profitable quarter
Medical device maker beats earnings estimates on strong AYON body contouring sales
Telix surges on Phase 3 prostate cancer trial success
PSMA-targeted therapy shows safety profile in 36 patients, paves way for global 490-patient expansion
Coherus BioSciences rises 6% on LOQTORZI growth despite earnings miss
Oncology drug revenue doubles to $40.8M while debt reduction strengthens balance sheet
Zevra Therapeutics surges after Q4 earnings crush estimates
Rare disease biotech swings to full-year profitability as MIPLYFFA treatment reaches 68% market access
Design Therapeutics rises 3% on earnings beat, pipeline progress
Biotech holds $219.8M cash to fund operations into 2029 as clinical programs advance